vs
丽思卡尔顿酒店集团（INN）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是丽思卡尔顿酒店集团的1.1倍（$197.9M vs $185.1M），REPLIGEN CORP净利率更高（6.7% vs -5.6%，领先12.4%），REPLIGEN CORP同比增速更快（13.6% vs 0.3%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -2.3%）
丽思卡尔顿酒店集团是源自美国的跨国豪华连锁酒店品牌，主打高端奢华住宿体验，目前在全球30个国家和地区运营着108家豪华酒店及度假村，共计拥有超过2.9万间客房，另有46家合计近9千间客房的项目正在筹备规划中。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
INN vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$185.1M
营收增速更快
RGEN
高出13.3%
0.3%
净利率更高
RGEN
高出12.4%
-5.6%
两年增速更快
RGEN
近两年复合增速
-2.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $197.9M |
| 净利润 | $-10.4M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 7.6% | 9.0% |
| 净利率 | -5.6% | 6.7% |
| 营收同比 | 0.3% | 13.6% |
| 净利润同比 | -122.9% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INNRGEN
| Q1 26 | $185.1M | — | ||
| Q4 25 | $175.0M | $197.9M | ||
| Q3 25 | $177.1M | $188.8M | ||
| Q2 25 | $192.9M | $182.4M | ||
| Q1 25 | $184.5M | $169.2M | ||
| Q4 24 | $172.9M | $174.1M | ||
| Q3 24 | $176.8M | $154.9M | ||
| Q2 24 | $193.9M | $154.1M |
净利润INNRGEN
| Q1 26 | $-10.4M | — | ||
| Q4 25 | $-2.6M | $13.3M | ||
| Q3 25 | $-11.8M | $14.9M | ||
| Q2 25 | $2.0M | $14.9M | ||
| Q1 25 | $623.0K | $5.8M | ||
| Q4 24 | $916.0K | $-30.3M | ||
| Q3 24 | $-3.6M | $-654.0K | ||
| Q2 24 | $38.7M | $3.3M |
毛利率INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率INNRGEN
| Q1 26 | 7.6% | — | ||
| Q4 25 | 8.3% | 9.0% | ||
| Q3 25 | 4.8% | 8.9% | ||
| Q2 25 | 11.8% | 7.6% | ||
| Q1 25 | 10.7% | 3.9% | ||
| Q4 24 | 4.6% | -17.7% | ||
| Q3 24 | 8.9% | -5.1% | ||
| Q2 24 | 29.0% | 1.0% |
净利率INNRGEN
| Q1 26 | -5.6% | — | ||
| Q4 25 | -1.5% | 6.7% | ||
| Q3 25 | -6.6% | 7.9% | ||
| Q2 25 | 1.1% | 8.2% | ||
| Q1 25 | 0.3% | 3.4% | ||
| Q4 24 | 0.5% | -17.4% | ||
| Q3 24 | -2.0% | -0.4% | ||
| Q2 24 | 20.0% | 2.2% |
每股收益（稀释后）INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | $-0.05 | $0.24 | ||
| Q3 25 | $-0.11 | $0.26 | ||
| Q2 25 | $-0.02 | $0.26 | ||
| Q1 25 | $-0.04 | $0.10 | ||
| Q4 24 | $0.05 | $-0.55 | ||
| Q3 24 | $-0.04 | $-0.01 | ||
| Q2 24 | $0.23 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $44.8M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $840.4M | $2.1B |
| 总资产 | $2.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资INNRGEN
| Q1 26 | $44.8M | — | ||
| Q4 25 | $36.1M | $767.6M | ||
| Q3 25 | $41.1M | $748.7M | ||
| Q2 25 | $39.5M | $708.9M | ||
| Q1 25 | $48.2M | $697.2M | ||
| Q4 24 | $40.6M | $757.4M | ||
| Q3 24 | $51.7M | $784.0M | ||
| Q2 24 | $45.9M | $809.1M |
总债务INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | $542.2M | ||
| Q3 25 | $1.4B | $537.9M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | $525.6M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
股东权益INNRGEN
| Q1 26 | $840.4M | — | ||
| Q4 25 | $862.2M | $2.1B | ||
| Q3 25 | $875.8M | $2.1B | ||
| Q2 25 | $895.1M | $2.1B | ||
| Q1 25 | $920.4M | $2.0B | ||
| Q4 24 | $909.5M | $2.0B | ||
| Q3 24 | $911.4M | $2.0B | ||
| Q2 24 | $931.9M | $2.0B |
总资产INNRGEN
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $2.9B | ||
| Q3 25 | $2.8B | $2.9B | ||
| Q2 25 | $2.9B | $2.9B | ||
| Q1 25 | $2.9B | $2.9B | ||
| Q4 24 | $2.9B | $2.8B | ||
| Q3 24 | $2.8B | $2.8B | ||
| Q2 24 | $2.9B | $2.9B |
负债/权益比INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.62× | 0.26× | ||
| Q3 25 | 1.62× | 0.26× | ||
| Q2 25 | 1.59× | — | ||
| Q1 25 | 1.54× | — | ||
| Q4 24 | 1.54× | 0.27× | ||
| Q3 24 | 1.47× | — | ||
| Q2 24 | 1.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 29.7% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | $149.0M | $25.7M | ||
| Q3 25 | $45.8M | $48.1M | ||
| Q2 25 | $48.8M | $28.6M | ||
| Q1 25 | $25.9M | $15.0M | ||
| Q4 24 | $166.3M | $39.2M | ||
| Q3 24 | $55.7M | $49.3M | ||
| Q2 24 | $50.3M | $42.2M |
自由现金流INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | $73.6M | $17.6M | ||
| Q3 25 | $24.0M | $43.4M | ||
| Q2 25 | $30.0M | $21.5M | ||
| Q1 25 | $10.1M | $11.4M | ||
| Q4 24 | $77.0M | $33.6M | ||
| Q3 24 | $33.1M | $42.3M | ||
| Q2 24 | $29.4M | $37.4M |
自由现金流率INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | 42.0% | 8.9% | ||
| Q3 25 | 13.5% | 23.0% | ||
| Q2 25 | 15.5% | 11.8% | ||
| Q1 25 | 5.5% | 6.8% | ||
| Q4 24 | 44.5% | 19.3% | ||
| Q3 24 | 18.7% | 27.3% | ||
| Q2 24 | 15.2% | 24.3% |
资本支出强度INNRGEN
| Q1 26 | 29.7% | — | ||
| Q4 25 | 43.1% | 4.1% | ||
| Q3 25 | 12.3% | 2.5% | ||
| Q2 25 | 9.8% | 3.9% | ||
| Q1 25 | 8.5% | 2.1% | ||
| Q4 24 | 51.6% | 3.2% | ||
| Q3 24 | 12.7% | 4.5% | ||
| Q2 24 | 10.8% | 3.1% |
现金转化率INNRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 23.97× | 1.92× | ||
| Q1 25 | 41.49× | 2.57× | ||
| Q4 24 | 181.58× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.30× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INN
| Pro forma room revenue | $162.1M | 88% |
| Pro forma other hotel operations revenue | $22.4M | 12% |
RGEN
暂无分部数据
